In accordance with Senate's Policy Regarding Inactive Courses, the course descriptions for courses which have not been offered in the previous three Academic years and which are not scheduled to be offered in the current Academic year have been removed from the following listing. For information about any of these inactive courses, please contact the Dean of the School.
A student is advised to pay attention to Usage Limitation (UL) for each course to determine its program applicability.
All courses of the School are designated by PHAR and are restricted to students in the School of Pharmacy.
2002
Anatomy and Physiology I
provides an overview of human anatomy and physiology throughout the lifespan. It includes aspects of cytology and histology that form a foundation for the practice of pharmacy. The focus will be on developing an understanding of the interrelationships and integration of all systems from the cell to whole organism. Special emphasis is given to the skeletal, muscular, nervous, and endocrine systems.
CR: Nursing 1002
LH: 2; attendance is required
2003
Anatomy and Physiology II
provides an overview of human anatomy and physiology throughout the lifespan. It includes aspects of cytology and histology that form a foundation for the practice of pharmacy. The focus will be on developing an understanding of the interrelationships and integration of all systems from cell to whole organism. Special emphasis is given to the circulatory, respiratory, urinary, digestive, and reproductive systems.
CR: Nursing 1012
LH: 2; attendance is required
2004
Introduction to Biochemistry
is an introduction to the major organic substances of living organisms, proteins, carbohydrates and lipids: their structure, analysis and biochemical function. Other topics include: enzymes; the biochemistry of membranes, including the plasma membrane and specialized intracellular membranes; and the biochemistry of selected differentiated cells.
CR: Biochemistry 2201 or the former 2101
PR: Chemistry 2400 and Physics 1020 (or 1050), and 1021 (or 1051)
2010
Service Learning
requires completion of 20 hours of service in the community in any term within the first year of the program. Students will engage in projects or activities which will benefit both the host organization and the student. It will occur in an approved setting either in the academic community or with an off-campus community group. The goal is to provide opportunities for the student to develop communication and self-reflective learning skills, acquire new frames of reference and perspectives, and gain an enhanced sense of civic responsibility.
CH: 0
OR: 20 hours of service learning
2201
Pharmaceutics I
provides an insight into a number of physicochemical basics and explains them within a pharmaceutical context. The course provides the basic foundation necessary for the study of pharmaceutical dosage forms, pharmacokinetics and bio-pharmaceutics.
LH: 3; attendance is required
PR: Mathematics 1000 and 1001; and Chemistry 1050 and 1051, or Chemistry 1200 and 1001, or equivalent; Science 1807 and Science 1808
2202
Pharmaceutics II
is designed to provide the student with an understanding of pharmaceutical dosage forms and their applications. It applies the principles taught in Pharmaceutics I to understand the design and components of the different pharmaceutical preparations.
LH: 3; attendance is required
2250
Pharmacy Practice I
begins the acquisition and application of the knowledge the knowledge, skills, and attitudes necessary for pharmacy practice. The course will include an introduction to calculations, technical skills and the legal and regulatory framework of pharmacy practice. Application will occur in simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, drug information, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study in order to pass the course.
AR: attendance is required in practice sessions
CH: 5
CO: all Academic Term 1 Pharmacy courses, with the exception of PHAR 2010
OR: practice sessions 2 hours per week
2251
Pharmacy Practice II
continues the acquisition, development, and application of the knowledge, skills, and attitudes necessary for pharmacy practice. The legal and professional framework of pharmacy practice, patient counselling, and technical skills will be emphasized. Application will take place in real and simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, drug information, communication, professionalism, critical thinking and teamwork at a level appropriate for the year of study to in order to pass the course.
AR: attendance is required in practice sessions
CH: 5
CO: all Academic Term 2 Pharmacy courses, with the exception of PHAR 2010
LC: 2
OR: practice sessions 3 hours per week
2610
Health Systems
provides an introduction to the Canadian healthcare system, its development, history, structure, and financing. The federal and provincial governments’ involvement in the healthcare system and health policy will be presented. The roles and responsibilities of the pharmacist within healthcare will also be examined.
2620
Social and Ethical Behaviour
introduces the social and cultural factors and determinants that influence health in Canada, and their ethical implications. Theoretical approaches from a social perspective, including value systems in Canada, ethical dilemmas and the role of ethics in pharmacy practice will be discussed.
CH: 2
LC: 2
PR: PHAR 2610
3006
Immunology
(same as Biochemistry 4105 and Biology 4200) is an introduction to the cells and organs of the innate and adaptive immune systems. The molecular and cellular basis of allergy, autoimmunity, vaccination and cancer immunology will also be discussed.
CR: Biochemistry 4105, Biology 4200, and the former PHAR 4105
PR: PHAR 2004
302W
Structured Practice Experience II
is a structured practice experience in hospital pharmacy after completion of the second year which will provide an opportunity for students to apply their technical skills and introduce them to patient care activities. The practical experience is normally comprised of four weeks during May/June.
AR: attendance is required
CH: 0
LC: 0
PR: successful completion of all courses in Academic Terms 3 & 4 of the program
UL: applicable only to the Bachelor of Science (Pharmacy) program
305P
Pharmacy Practice Experience I
provides six weeks (240 hours) of practice experience in a community pharmacy. The focus will be on the legal and regulatory framework governing pharmacy practice, prescription processing, gathering and assessing patient information, patient education, drug information, health promotion, and quality assurance. Students will apply their knowledge and skills in the provision of patient care. Effective communication skills, professionalism, and teamwork are expected.
AR: attendance is required
PR: all Academic Term 4 & 5 courses
3111
General Biochemistry
covers the catabolism of carbohydrates, lipids and amino acids. Mitochondria, chloroplasts and ATP synthesis. Biosynthesis of carbohydrates and lipids. Metabolic specialization of differentiated cells and tissues. Integration of metabolism.
3250
Pharmacy Practice III
continues the acquisition, development, and application of the knowledge, skills, and attitudes necessary for pharmacy practice. The focus will include patient assessment, care plan development, counselling, follow-up, interprofessional collaboration, and communication with special patient populations. Application will occur in real and simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, drug information, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study to pass the course.
AR: attendance is required
CH: 5
CO: all Academic Term 4 Pharmacy courses
LC: 2
OR: practice sessions 3 hours per week
3251
Pharmacy Practice IV
continues the acquisition, development, and application of the knowledge, skills, and attitudes necessary for pharmacy practice. This course will build on pharmacy practice concepts and will emphasize patient safety. Application will take place in simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, drug information, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study in order to pass the course.
AR: attendance is required
CH: 5
CO: all Academic Term 5 Pharmacy courses
LC: 2
OR: practice sessions 3 hours per week
3270
Pharmacotherapy I
introduces pharmacotherapeutic management of common diseases and effective management of patients’ drug therapy. Emphasis will be placed on identifying drug therapy problems, establishing therapeutic outcomes, recommending pharmacological and non-pharmacological therapeutic alternatives, developing individualized therapeutic regimens, and developing a monitoring plan to evaluate adherence, efficacy, and safety. Topics may include drug interactions, gastroenterological conditions, musculoskeletal conditions, nutrition, and special populations.
CH: 5
LC: 5
3271
Pharmacotherapy II
continues the discussion of pharmacotherapeutic management of common diseases and effective management of patients’ drug therapy. Emphasis will be placed on identifying drug therapy problems, establishing therapeutic outcomes, recommending pharmacological and non-pharmacological therapeutic alternatives, developing individualized therapeutic regimens, and developing a monitoring plan to evaluate adherence, efficacy, and safety. Topics may include cardiovascular, dermatological, respiratory, and infectious diseases.
CH: 4
CO: PHAR 3251
LC: 4
3410
Leadership and Health Promotion
focuses on the roles of leadership, advocacy, and health promotion in pharmacy to improve patient care. Insight into leadership skills and the roles of educating, advocating, and promoting health to patients, families, communities, and society will be discussed. The change process and the leader’s role in change will be introduced.
3801
Pathophysiology I
examines the nature of disease, causes and effects, and alterations in structure and function of cells. Topics may include cardiovascular, dermatological, gastrointestinal, and respiratory diseases.
CH: 2
LC: 2
PR: PHAR 2003
3805
Pharmacology I
provides an introduction to the general principles of pharmacology including dose-response relationships, drug-receptor interactions, absorption, distribution, metabolism, and elimination of drugs. The focus will be on the pharmacological basis of the action of drugs leading to therapeutic effects, as well as adverse effects. Topics may include drugs used in the management of cardiovascular, gastrointestinal, respiratory diseases, and anti-inflammatory drugs.
PR: PHAR 2003
3810
Microbiology of Infectious Diseases
examines the various types of micro-organisms (bacterial, viral, parasitic, and fungal), microbial growth, and their relationship to human diseases. The classifications of their morphology, mode of reproduction, and the metabolic process will be discussed.
CH: 2
LC: 2
3825
Medicinal Chemistry
examines the functional group recognition and properties of drugs, drug-receptor interactions, structure activity relationships, and rational drug design. The relationship between the chemical structure of a drug and its binding affinity toward intended target enzymes or receptors, and its pharmacological activity, will be discussed.
CR: the former PHAR 3203 and the former 3204
4008
Chemotherapy
presents the principles of infectious diseases and cancer chemotherapy. Topics to be explored include molecular structure profiles in relation to mechanism of action, drug resistance, and toxicity of antimicrobial, antiviral, and antineoplastic agents. Antimicrobial activity/spectrum of activity of antibacterials, antifungals, antimalarial, antituberculosis, and antiviral/antiretroviral agents will be discussed. The classification and mechanism of action of cancer chemotherapeutic agents will be presented. Pharmacokinetic considerations, adverse effects/toxicity, and drug interactions will be explored for these agents.
CH: 2
CO: PHAR 4401
LC: 2
OR: tutorials 1 hour per week
PR: Medicine 4300, PHAR 3006, the former 3009, the former 3103, the former 3203, and the former 3204
UL: applicable only to the Bachelor of Science (Pharmacy) program
403W
Structured Practice Experience III
is a structured practice experience in community pharmacy after completion of the third year which will provide an opportunity for students to apply their technical skills and practice and participate in patient care activities. The practical experience is normally comprised of four weeks during May/June.
AR: attendance is required
CH: 0
LC: 0
PR: successful completion of all courses in Academic Terms 5 & 6 of the program
UL: applicable only to the Bachelor of Science (Pharmacy) program
406P
Pharmacy Practice Experience II
provides two weeks (80 hours) of practice experience in a hospital pharmacy practice setting. The focus will be on the operations of a hospital pharmacy, including drug distribution, policies and procedures, and communicating with other healthcare professionals. Students will apply their knowledge and skills in the provision of pharmacy services. Effective communication skills, professionalism, and teamwork are expected.
AR: attendance is required
CH: 1
PR: all Academic Term 7 & 8 courses
407P
Pharmacy Practice Experience III
provides four weeks (160 hours) of practice experience in a direct patient care setting. Emphasis will be on continuing to develop patient care skills by working with a variety of patients and the healthcare team to appropriately identify, prevent, and resolve drug-related problems. Effective communication skills, professionalism, and teamwork, are expected.
AR: attendance is required
CH: 2
PR: all Academic Term 7 & 8 courses
4201
Applied Pharmacokinetics
(same as the former PHAR 3206) is an introduction to biopharmaceutical and pharmacokinetic principles used in the selection, dosing, monitoring and evaluation of drug therapy. Application of these principles in evaluating drug literature and developing drug dosage regimens of selected classes of drugs for individual patients will be discussed.
CR: the former PHAR 3206
PR: Medicine 4300, PHAR 2202 and the former 3009
UL: applicable only to the Bachelor of Science (Pharmacy) program
4250
Pharmacy Practice V
continues the acquisition, development, and application of the knowledge, skills, and attitudes necessary for pharmacy practice. Critical appraisal, patient safety, and interprofessional collaboration will be emphasized. Application take place in simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, drug information, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study in order to pass the course.
AR: attendance is required in practice sessions
CH: 5
CO: all Academic Term 7 Pharmacy courses
LC: 2
OR: practice sessions 3 hours per week
4251
Pharmacy Practice VI
continues the acquisition, development, and application of the knowledge, skills, and attitudes necessary for pharmacy practice. Sterile product preparation, drug information, patient safety, and calculations relevant to hospital practice will be introduced. Critical appraisal and interprofessional collaboration will continue. Application will take place in simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study to pass the course.
AR: attendance is required in practice sessions
CH: 5
CO: all Academic Term 8 Pharmacy courses
LC: 2
OR: practice sessions 3 hours per week
4270
Pharmacotherapy III
continues the discussion of pharmacotherapeutic management of common diseases and effective management of the patient’s drug therapy. Emphasis will be placed on identifying drug therapy problems, establishing therapeutic outcomes, recommending pharmacological and non-pharmacological therapeutic alternatives, developing individualized therapeutic regimens, and developing a monitoring plan to evaluate adherence, efficacy, and safety. Topics may include autoimmune, infectious, and musculoskeletal diseases.
CH: 4
LC: 4
4271
Pharmacotherapy IV
continues the discussion of pharmacotherapeutic management of common diseases and effective management of patients’ drug therapy. Emphasis will be placed on identifying drug therapy problems, establishing therapeutic outcomes, recommending pharmacological and non-pharmacological therapeutic alternatives, developing individualized therapeutic regimens, and developing a monitoring plan to evaluate adherence, efficacy, and safety. Topics may include cardiovascular, endocrine and renal disease, and women’s and men’s health.
CH: 6
CO: PHAR 4251
LC: 6
4302
Patient Care II
discusses the principal roles of health systems and health policy with a special emphasis on pharmaceutical policy and its impact on the profession, the public and on the delivery of pharmaceutical care. The principles of health promotion and the role of the pharmacist will be discussed. Students will gain knowledge about health challenges facing society, how education affects health, the roles of the pharmacist in educating and promoting health to patients.
CH: 1
CR: the former PHAR 4301 and the former 3501
PR: the former PHAR 3301, and the former 2101 and the former 2102
UL: applicable only to the Bachelor of Science (Pharmacy) program
4401
Therapeutics I
is a part of a series that looks at the therapeutic management of common diseases. Topics may include but are not restricted to infectious diseases, hematology/oncology, and dermatology. For each disease state discussion will centre around several key issues including: the establishment of desired therapeutic outcomes; development of appropriate pharmacological and non-pharmacological therapeutic alternatives; factors to be considered to aid in the selection of an individualized therapeutic regimen; and the development of a monitoring plan to evaluate efficacy and safety.
CH: 6
LC: 6
OR: tutorials 2 hours per week; attendance is required
PR: Medicine 4300, PHAR 3006 and the former 3009
UL: applicable only to the Bachelor of Science (Pharmacy) program
4402
Therapeutics II
is a part in a series that looks at the therapeutic management of common diseases. Topics may include but are not restricted to women’s health, mens’ health, gastroenterology, musculoskeletal, neurological, respiratory disorders and transplantation. For each disease state discussion will centre around several key issues including: the establishment of desired therapeutic outcomes; development of appropriate pharmacological and non-pharmacological therapeutic alternatives; factors to be considered to aid in the selection of an individualized therapeutic regimen; and the development of a monitoring plan to evaluate efficacy and safety.
CH: 6
LC: 6
OR: tutorials 2 hours per week; attendance is required
PR: PHAR 4401
UL: applicable only to the Bachelor of Science (Pharmacy) program
4420
Pharmacy Management I
introduces the principles of management and leadership as they relate to pharmacy practice. Topics will include the pharmacy practice environment, human resources management, financial management, operations management, marketing, risk management, quality control and improvement, and effective communications.
4503
Pharmacy Administration
introduces students to the basic principles of management as it relates to pharmacy practice. Topics will include human resources and financial management, marketing, strategic planning and the principles and issues associated with safe and appropriate drug distribution. These will be discussed from both a community and an institutional practice focus.
UL: applicable only to the Bachelor of Science (Pharmacy) program
4504
Pharmacy Research and Evaluation I
introduces the biostatistical, pharmacoepidemiologic and pharmacoeconomic concepts and develops the skills necessary to the practice of research and evaluation methods in applied pharmacy. The understanding of such methods is an important prerequisite in the critical appraisal of the health literature and the undertaking of evidence-based clinical practice.
CR: the former PHAR 4501
UL: applicable only to the Bachelor of Science (Pharmacy) program
4505
Pharmacy Research and Evaluation II
introduces students to principles of critical appraisal and provides opportunities to apply these principles to critique and evaluate current medical literature. Students will be assigned to a tutorial group, which will meet twice during the term to critically appraise at least two recently published studies (journal club). Emphasis will be placed on appropriate application of critical appraisal skills and group discussion of impact of study findings on clinical practice. In addition, this course will also discuss drug utilization reviews and evaluations and the role of the pharmacist, as well as adverse drug event reporting and the role of the pharmacist.
CH: 1
CR: the former PHAR 4502
LC: 1
OR: tutorials 1 hour per week; attendance is required
PR: PHAR 4504 or equivalent
UL: applicable only to the Bachelor of Science (Pharmacy) program
4620
Applied Health Research
introduces the fundamentals of research design, methods, and appraisal necessary to develop the skills to analyze and interpret clinical research. Topics include randomized clinical trials, observational studies, and pharmacoeconomic evaluations. Emphasis will be placed on making valid inferences about drug safety and effectiveness from scientific research. Principles of critically appraising the medical literature will be introduced.
CO: Statistics 2550
4650
Pharmacy Skills
continues the development of the skills necessary for pharmacy practice in order to meet the educational outcomes for the third year of the pharmacy program. Students will continue to develop abilities in communication, professionalism, critical thinking, problem-solving, teamwork and self-directed learning. Students will participate in practice sessions necessary to develop an understanding of and skills required in patient assessment. Students will build on their pharmacist care skills to meet patients' drug-related needs in more complex patient scenarios, drug information skills to assess information needs, and medication preparation and dispensing skills to optimize safe and accurate medication delivery. Scenarios will relate to the courses of study in the third year and draw on material studies in earlier years of the program. Students will participate in interprofessional education (IPE) modules with students from other health related programs when such modules are available.
CO: all Academic Term 5 Pharmacy courses
CR: the former PHAR 4150
LC: 0
OR: practical sessions 3 hours per week; tutorials 1 hour per week; attendance is required
PR: Science 1807 and Science 1808
UL: applicable only to the Bachelor of Science (Pharmacy) program
4651
Pharmacy Skills
continues the development of the skills necessary for pharmacy practice in order to meet the educational outcomes for the third year of the pharmacy program. Students will continue to develop abilities in communication, professionalism, critical thinking, problem-solving, teamwork and self-directed learning. Students will participate in sessions that focus on ethical issues in pharmacy practice and communication with health care providers. Students will build on their patient assessment and pharmacist care skills to meet patients' drug-related needs in more complex patient scenarios and will use critical appraisal skills to respond to clinical questions. Scenarios will relate to the courses of study in the third year and draw on material studied in earlier years of the program. Students will participate in interprofessional education (IPE) modules with students from other health related programs when such modules are available.
CO: all Academic Term 6 Pharmacy courses
CR: the former PHAR 4151
LC: 0
OR: practical sessions 3 hours per week; tutorials 1 hour per week; attendance is required
PR: PHAR 4650; Science 1807 and Science 1808
UL: applicable only to the Bachelor of Science (Pharmacy) program
4802
Pathophysiology II
examines the nature of disease, causes and effects, and alterations in structure and function of cells. Topics may include endocrine disorders, renal, rheumatological and neurological diseases, neoplasia, and women’s and men’s health.
PR: PHAR 3801
4810
Pharmacology II
will focus on the pharmacological basis of the action of drugs leading to therapeutic effects, as well as adverse effects. Topics may include drugs used in the management of infectious diseases, the endocrine system, and inflammatory diseases, as well as hormonal drugs and analgesics.
CH: 2
LC: 2
4820
Pharmacokinetics
is an introduction to the biopharmaceutical and pharmacokinetic principles used in the selection, dosing, and monitoring of drug therapy. The concepts of absorption, distribution, metabolism and elimination, pharmacokinetic and pharmacodynamics mechanisms of drug interactions, and the importance of drug monitoring will be explored.
CH: 2
LC: 2
4860
Pharmacogenomics and Biotechnology
provides insight into the development of biopharmaceuticals. Formulation, stability, dispensing, and clinical applications of biotechnology derived protein/peptide drugs will be discussed. The fundamental concepts of pharmacogenetics and pharmacogenomics will be explored. A focus will be on understanding how personalized drug therapy, based on the genetic profile of individuals, can optimize drug therapy and patient care.
CH: 2
LC: 2
4900
Clinical Skills I
is an on-campus, three-day (21 hours) orientation to the fundamental knowledge and skills for advanced practice. Topics such as informatics, communication, and patient assessment may be explored. This course may commence outside the semester start and end dates.
AR: attendance is required
CH: 2
UL: applicable only to the Doctor of Pharmacy for Working Professionals
4901
Essentials of Pharmacy Practice
provides the foundational principles and skills of pharmacy practice such as the provision of patient-centred care, pharmacokinetics, and social justice. The pass grade is 60%.
CH: 4
UL: applicable only to the Doctor of Pharmacy for Working Professionals
4902
Pharmacy Management and Leadership
explores the principles of change management and leadership as they relate to pharmacy practice. Topics may include the business environment, financial management, continuous quality improvement, business marketing and promotion, human resources management, pharmacy services implementation, effective pharmacy operations, and technology in pharmacy practice. The pass grade is 60%.
CH: 2
UL: applicable only to the Doctor of Pharmacy for Working Professionals
4903
Evidence-Based Practice
integrates advanced drug information and critical evaluation of the medical literature. Students will apply their knowledge of pharmacy practice research and evidence-based practice to inform therapeutic decision-making. The pass grade is 60%.
PR: PHAR 4900
UL: applicable only to the Doctor of Pharmacy for Working Professionals
4910
Applied Learning I
focuses on the application of leadership skills to implement change in practice through education and advocacy. Students will demonstrate their learning through the completion of applied learning activities at their practice sites.
PR: PHAR 4902
UL: applicable only to the Doctor of Pharmacy for Working Professionals
500X
Structured Practice Experience IV
provides experience in clinical practice. Students will participate as members of the health care team. They will be responsible for providing pharmaceutical care to patients. Activities will include attending patient care rounds, providing in-services and drug information, and participating in case presentations. The structured practice experience is comprised of two six week modules.
AR: attendance is required
CH: 18
LC: 0
PR: successful completion of all course requirements for the degree and Clear Promotion
UL: applicable only to the Bachelor of Science (Pharmacy) program
508P
Pharmacy Practice Experience IV
provides two weeks (80 hours) of practice experience during Academic Term 11 in an institutional direct patient care setting. This course serves as a transition to the Advanced Pharmacy Practice Experience. Emphasis will be on developing independence in providing patient care under the mentorship of a preceptor or of an advanced practice pharmacy student. Effective communication skills, professionalism, and teamwork are expected.
AR: attendance is required
CH: 1
PR: all Academic Term 10 courses
5250
Pharmacy Practice VII
continues the acquisition, development, and application of the knowledge, skills, and attitudes necessary for pharmacy practice. Critical appraisal, patient safety, and interprofessional collaboration will be emphasized. Students will be expected to demonstrate increased independence during the application of knowledge and skills in simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study in order to pass the course.
AR: attendance is required in practice sessions
CH: 5
CO: all Academic Term 10 Pharmacy courses
LC: 2
OR: practice sessions 3 hours per week
5251
Pharmacy Practice VIII
is the final course in the series where students acquire, develop, and apply the knowledge, skills, and attitudes necessary for pharmacy practice. Application of knowledge and skills will occur in simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, drug information, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study in order to pass the course.
AR: attendance is required in practice sessions
CH: 4
CO: all Academic Term 11 Pharmacy courses
LC: 2
OR: practice sessions 3 hours per week; course runs over 10 weeks to accommodate PHAR 508P
5270
Pharmacotherapy V
is the final course in the series that examines the pharmacotherapeutic management of common diseases and effective management of the patient’s drug therapy. Emphasis will be placed on identifying drug therapy problems, establishing therapeutic outcomes, recommending pharmacological and non-pharmacological therapeutic alternatives, developing individualized therapeutic regimens, and developing a monitoring plan to evaluate adherence, efficacy, and safety. Topics may include neurological, oncological, and addictions and mental health conditions.
CH: 6
CO: PHAR 5815
LC: 6
PR: PHAR 4271
5271
Advanced Pharmacotherapy
expands and integrates the knowledge and skills acquired from the Pharmacotherapy series of courses through application to complex patient scenarios. Critical thinking skills necessary for optimizing pharmacotherapy in a variety of patient care situations will be the focus of the course.
CH: 5
LC: 6
OR: course runs over 10 weeks to accommodate PHAR 508P
PR: PHAR 5270
5275
Symposium in Pharmacy
is a forum for students to research, develop and deliver formal presentations related to pharmacy practice. Students will be expected to interpret, synthesize, and present information effectively. The presentations will allow for application of knowledge and reflection on content.
AR: attendance is required
CH: 2
CO: PHAR 5251
LC: 2
5301
Clinical Toxicology
covers the toxicology and clinical management of toxicity associated with common medications.
CH: 2
CO: PHAR 5401
LC: 2
UL: applicable only to the Bachelor of Science (Pharmacy) program
5302
Patient Care III
focuses on pharmaceutical care considerations in special patient populations (e.g., geriatrics, neonates, pediatrics, pregnancy and lactation, critically ill, etc.). Implementation of pharmaceutical care in hospital, ambulatory and community practice settings will be discussed.
CO: PHAR 5401
OR: tutorials 1 hour per week; attendance is required
UL: applicable only to the Bachelor of Science (Pharmacy) program
5401
Therapeutics III
is part in a series that looks at the therapeutic management of common diseases. Topics may include but are not restricted to endocrine, psychiatric, renal and cardiovascular disorders. For each disease state discussion will centre around several key issues including: the establishment of desired therapeutic outcomes; development of appropriate pharmacological and non-pharmacological therapeutic alternatives; factors to be considered to aid in the selection of an individualized therapeutic regimen; and the development of a monitoring plan to evaluate efficacy and safety.
CH: 6
LC: 6
OR: tutorials 2 hours per week
PR: PHAR 4402
UL: applicable only to the Bachelor of Science (Pharmacy) program
5430
Pharmacy Management II
prepares students for the various roles of management in pharmacy practice, regardless of position or practice setting. Management principles including communications, leadership, finance, human resources management, marketing, and promotion will be applied through demonstrating leadership, business planning, and pharmacy service implementation.
CH: 2
LC: 2
PR: PHAR 4420
5506
Pharmacy Research and Evaluation III
(same as the former PHAR 5501) discusses the principles of critical appraisal and provides opportunities to apply these principles to critique and evaluate current medical literature. Students will be assigned to a tutorial group, which will meet twice during the term to critically appraise at least two recently published studies. Emphasis will be placed on appropriate application of critical appraisal skills and group discussion of impact of study findings on clinical practice.
CH: 1
CR: the former PHAR 5501
LC: 0
OR: tutorials 1 hour per week
PR: PHAR 4505 or equivalent
UL: applicable only to the Bachelor of Science (Pharmacy) program
5640
Social Justice and the Pharmacist
will enable students to critically analyse the role of social justice as an integral part of the practice of pharmacy. The course will include a focus on the interconnectedness of health equity with global contexts that include social class, ethnicity, gender, ability, and mental health. Critical thinking skills will be used to examine complex health and social issues.
CH: 2
LC: 2
5650
Pharmacy Skills
(same as the former PHAR 5150) continues the development of the skills necessary for pharmacy practice in order to meet the educational outcomes for the fourth year of the pharmacy program. Students will continue to develop abilities in communication, professionalism, critical thinking, problem-solving, teamwork and self-directed learning. Students will build on their pharmacist care skills to meet patients’ drug-related needs in patients with multiple drug related problems. Refinement of verbal and written communication skills will be focus. Scenarios will relate to the courses of study in the fourth year and draw on material studies in earlier years of the program. Students will participate in interprofessional education (IPE) modules with students from other health related programs when such modules are available.
CO: all Academic Term 7 Pharmacy courses
CR: the former PHAR 5150
LC: 0
OR: practical sessions 3 hours per week; tutorials 1 hour per week; attendance is required
PR: Science 1807 and Science 1808
UL: applicable only to the Bachelor of Science (Pharmacy) program1
5815
Pharmacology III
is the final course in the series that focuses on the pharmacological basis of the action of drugs leading to therapeutic effects, as well as adverse effects. Topics may include drugs used in the management of oncological, mental health, and neurological conditions as well as drugs of abuse.
CH: 2
CO: PHAR 5270
LH: 2
PR: PHAR 4810
5830
Applied Pharmacokinetics
discusses pharmacokinetic principles of drug selection, dosing, and monitoring in the clinical setting for individualization of drug therapy.
CH: 2
LH: 2
PR: PHAR 4820
5901
Pharmaceutical Care I
integrates the knowledge and skills necessary for the effective management of medication therapy in the provision of patient-centred care. Students will apply their knowledge of patient assessment, pharmacotherapy, and evidence-based practice to evaluate therapeutic options primarily for diseases of the cardiovascular system. The pass grade is 60%.
PR: PHAR 4903
UL: applicable only to the Doctor of Pharmacy for Working Professionals
5902
Pharmaceutical Care II
integrates the knowledge and skills necessary for the effective management of medication therapy in the provision of patient-centred care. Students will apply their knowledge of patient assessment, pharmacotherapy, and evidence-based practice to evaluate therapeutic options primarily for renal, digestive, and oncological diseases. The pass grade is 60%.
PR: PHAR 4903
UL: applicable only to the Doctor of Pharmacy for Working Professionals
5903
Pharmaceutical Care III
integrates the knowledge and skills necessary for the effective management of medication therapy in the provision of patient-centred care. Students will apply their knowledge of patient assessment, pharmacotherapy, and evidence-based practice to evaluate therapeutic options primarily for diseases of the protective, structural, and endocrine systems. The pass grade is 60%.
PR: PHAR 4903
UL: applicable only to the Doctor of Pharmacy for Working Professionals
5904
Pharmaceutical Care IV
integrates the knowledge and skills necessary for the effective management of medication therapy in the provision of patient-centred care. Students will apply their knowledge of patient assessment, pharmacotherapy, and evidence-based practice to evaluate therapeutic options primarily for respiratory and infectious diseases. The pass grade is 60%.
PR: PHAR 4903
UL: applicable only to the Doctor of Pharmacy for Working Professionals
5905
Pharmaceutical Care V
integrates the knowledge and skills necessary for the effective management of medication therapy in the provision of patient-centred care. Students will apply their knowledge of patient assessment, pharmacotherapy, and evidence-based practice to evaluate therapeutic options primarily for neurological disorders and mental health conditions. The pass grade is 60%.
PR: PHAR 4903
UL: applicable only to the Doctor of Pharmacy for Working Professionals
5920
Applied Learning II
focuses on the principles of medication safety, medication use evaluation, adverse drug events, and medication errors and incident reporting. Students will demonstrate their learning through the completion of applied learning activities at their practice sites.
PR: PHAR 4910 and at least one of PHAR 5901, 5902, 5903, 5904, 5905
UL: applicable only to the Doctor of Pharmacy for Working Professionals
605P
Advanced Pharmacy Practice Experience: Direct Patient Care
is an eight week (320 hours) practice experience completed during the final year of the program (following Academic Term 11). Students will be expected to demonstrate leadership in the responsible provision of patient care by becoming an integral member of the healthcare team while confidently using clinical reasoning and critical thinking skills. Mentorship of junior students may be a component of this experience.
AR: attendance is required
CH: 12
PR: all Academic Term 10 & 11 courses
606P
Advanced Pharmacy Practice Experience: Acute Care Hospital
is an eight week (320 hours) practice experience where patient care is provided in an acute care hospital setting and is completed during the final year of the program (following Academic Term 11). Students will be expected to demonstrate leadership in the responsible provision of patient care by becoming an integral member of the healthcare team while confidently using clinical reasoning and critical thinking skills. Mentorship of junior students may be a component of this experience.
AR: attendance is required
CH: 12
PR: all Academic Term 10 & 11 courses
607P
Advanced Pharmacy Practice Experience: Community Pharmacy
is an eight week (320 hours) practice experience where patient care is provided in a community pharmacy setting and is completed during the final year of the program (following Academic Term 11). Students will be expected to demonstrate leadership in the responsible provision of patient care by applying expanded scope of practice skills, as well as communicating and collaborating with patients, the pharmacy team, other health professionals, and the public while confidently using clinical reasoning and critical thinking skills. Mentorship of junior students may be a component of this experience.
AR: attendance is required
CH: 12
PR: all Academic Term 10 & 11 courses
608P
Advanced Pharmacy Practice Experience: Elective
is a six week (240 hours) experience completed during the final year of the program (following Academic Term 11). The experience may occur in either a direct or non-direct patient care setting. Options include patient care, research, health policy, drug information, teaching/education, advocacy, and administration. Placements may vary from year to year depending upon site and preceptor availability.
AR: attendance is required
CH: 9
PR: all Academic Term 10 & 11 courses
610P
Advanced Pharmacy Practice Experience: Ambulatory Care
is a six week (240 hours) practice experience completed during the final year of the program. Students will develop their medication therapy management skills and pharmaceutical care in an ambulatory care setting. Students will be expected to demonstrate leadership in the responsible provision of patient care by becoming an integral member of the healthcare team while confidently using clinical reasoning and critical thinking skills. Mentorship of junior students may be a component of this experience.
AR: attendance is required
CH: 9
PR: PHAR 6900, 6930 and at least four of PHAR 5901, 5902, 5903, 5904, 5905
UL: applicable only to the Doctor of Pharmacy for Working Professionals
611P
Advanced Pharmacy Practice Experience: Inpatient Care
is a six week (240 hours) practice experience completed during the final year of the program. Students will develop the essential skills necessary to provide direct patient care in an inpatient setting. Students will be expected to demonstrate leadership in the responsible provision of patient care by becoming an integral member of the healthcare team while confidently using clinical reasoning and critical thinking skills. Mentorship of junior students may be a component of this experience.
AR: attendance is required
CH: 9
PR: PHAR 6900, 6930 and at least four of PHAR 5901, 5902, 5903, 5904, 5905
UL: applicable only to the Doctor of Pharmacy for Working Professionals
6900
Clinical Skills II
is an on-campus, three-day (21 hours) introduction to the Advanced Pharmacy Practice Experience component of the program. The focus will be on topics that enable students to practice to their full scope. Students will continue to demonstrate skills in communication, patient assessment, and documentation. This course may commence outside the semester start and end dates.
AR: attendance is required
CH: 2
CO: PHAR 6930
PR: PHAR 4900
UL: applicable only to the Doctor of Pharmacy for Working Professionals
6930
Applied Learning III
focuses on the expansion of skills in patient assessment, communication, documentation, and interprofessional collaboration through the provision of patient-centred care. Students will demonstrate their learning through the completion of applied learning activities at their practice sites.
CO: PHAR 6930
PR: PHAR 5920 and at least three of PHAR 5901, 5902, 5903, 5904, 5905
UL: applicable only to the Doctor of Pharmacy for Working Professionals